Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody 12-12-2024, 04:35

Matterport Announces Genesis: A Generative AI Initiative to Transform How Buildings are Designed, Built, and Managed 14-06-2023, 20:00

Colliers partners with global infrastructure investment bank 5-06-2025, 03:05